Autonomix Medical Files Proxy Materials

TL;DR

Autonomix Medical filed proxy materials for its 2024 meeting, shareholders get to vote.

AI Summary

Autonomix Medical, Inc. filed a Definitive Additional Materials proxy statement on September 5, 2024, related to its 2024 annual meeting. The filing indicates no fee was required for this submission, and it is being made available to shareholders.

Why It Matters

This filing provides shareholders with important information and voting materials for the company's upcoming annual meeting, allowing them to participate in corporate governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing information to shareholders and does not indicate any unusual financial or operational risks.

Key Players & Entities

• Autonomix Medical, Inc. (company) — Registrant
• 0001437749-24-028441 (filing_id) — Accession Number
• 20240905 (date) — Filing Date
• 20240904 (date) — Date as of Change

FAQ

Filing Documents

• amix20240903_defa14a.htm (DEFA14A) — 25KB
• a01.jpg (GRAPHIC) — 1KB
• a02.jpg (GRAPHIC) — 1KB
• a03.jpg (GRAPHIC) — 1KB
• a04.jpg (GRAPHIC) — 1KB
• 0001437749-24-028441.txt ( ) — 32KB

From the Filing

amix20240903_defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Autonomix Medical, Inc. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 Autonomix Medical Inc. CONTROL ID: IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON OCTOBER 17, 2024. DATE: October 17, 2024 TIME: AT 10:00 AM Central Time LOCATION: at the principal executive offices of the Company at 21 Waterway Avenue, Suite 300, The Woodlands, TX 77380 THIS COMMUNICATION IS NOT A FORM OF VOTING AND ONLY REPRESENTS A NOTICE TO ACCESS A MORE COMPLETE SET OF PROXY MATERIALS (INCLUDING THE PROXY STATEMENT AND FORM 10 K ) AVAILABLE TO YOU ON THE INTERNET. WE ENCOURAGE YOU TO ACCESS AND REVIEW ALL OF THE IMPORTANT INFORMATION CONTAINED IN THE PROXY MATERIALS BEFORE VOTING. THE PROXY MATERIALS ARE AVAILABLE AT www.AMIX.vote TO SUBMIT YOUR PROXY WHILE VISITING THIS SITE, YOU WILL NEED THE CONTROL ID IN THIS NOTICE. IF YOU DECIDE TO VIEW THE PROXY MATERIALS AND VOTE YOUR SHARES ONLINE, Step 1: Go to www.AMIX.vote Step 2: To view or download the proxy materials, click on the link that describes the material you wish to view or download. For example, to view or download the Proxy Statement, click on the "Proxy Statement" link. Step 3: To vote online, click on the designated link and follow the on-screen instructions. YOU MAY VOTE ONLINE UNTIL 7:00 PM EASTERN TIME ON October 16, 2024 . IF YOU WANT TO RECEIVE A PAPER COPY OF THE PROXY MATERIALS INCLUDING THE PROXY CARD, YOU MUST REQUEST ONE. THERE IS NO CHARGE TO YOU FOR REQUESTING A COPY. TO FACILITATE TIMELY DELIVERY PLEASE MAKE THE REQUEST, AS INSTRUCTED BELOW, BEFORE OCTOBER 2, 2024 . HOW TO REQUEST PAPER COPIES OF OUR MATERIALS PHONE: FAX: INTERNET: EMAIL: CALL TOLL FREE SEND THIS CARD TO www.AMIX.vote proxy@equitystock.com 1-212-575-5757 1-347-584-3644 FOLLOW THE ON-SCREEN INSTRUCTIONS. INCLUDE YOUR CONTROL ID IN YOUR EMAIL. VOTING ITEMS THE BOARD OF DIRECTORS OF AUTONOMIX MEDICAL INC. (THE " COMPANY " ) RECOMMENDS THAT YOU VOTE " FOR " EACH NOMINEE ON PROPOSAL 1, AND " FOR " PROPOSAL 2 AND 3. 1. To elect five Board nominees to the Board of Directors of the Company, each to serve until the 2025 annual meeting of stockholders of the Company or until such person's successor is qualified and elected. 2. To ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the year ending March 31, 2025. 3. To approve an amendment to the Company's amended and restated certificate of incorporation to grant our Board of Directors authority to effect a reverse stock split of the outstanding shares of the Company's common stock, at a reverse stock split ratio of between 1-for-2 to 1-for-50 (or any whole number in between), as determined by the Board in its sole discretion, prior to the one-year anniversary of this Annual Meeting. Note: To transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof. THE BOARD OF DIRECTORS HAS FIXED THE CLOSE OF BUSINESS ON AUGUST 26, 2024, AS THE RECORD DATE FOR THE DETERMINATION OF SHAREHOLDERS ENTITLED TO RECEIVE NOTICE OF THE SPECIAL MEETING AND TO VOTE THE COMPANY'S COMMON SHARES THEY HELD ON THAT DATE AT THE MEETING OR ANY POSTPONEMENT OR ADJOURNMENT OF THE MEETING. PLEASE NOTE – THIS IS NOT A PROXY CARD - YOU CANNOT VOTE BY RETURNING THIS CARD. TO VOTE YOUR SHARES, YOU MUST VOTE ONLINE OR REQUEST A PAPER COPY OF PROXY MATERIALS TO RECEIVE A PROXY CARD. IF YOU WISH TO ATTEND AND VOTE AT THE MEETING, PLEASE FOLLOW INSTRUCTIONS LISTED ON THE REVERSE SIDE. YOUR VOTE IS IMPORTANT!

View Full Filing

View this DEFA14A filing on SEC EDGAR